Literature DB >> 22235633

[Factors justifying the choice of labor epidural analgesia by nulliparous women: experience at a maternity center in Antananarivo, Madagascar].

J A C Ramorasata, N E Raveloson, R Randriamahavonjy, D Tohaina, H Keita.   

Abstract

Epidural analgesia is the most effective method for pain relief during labor. This 10-year exploratory descriptive study on factors underlying women's decisions to request or refuse labor epidural analgesia (LEA) was carried out at a level III maternity hospital in Antananarivo, Madagascar. All patients underwent a pre-anesthesia check-up (PAC) between 32 and 34 weeks of amenorrhea. During the PAC, a questionnaire was administered to determine socio-economic aspects, level of education, and knowledge about labor pain and LEA. In addition, LEA was proposed and patients were asked to explain their reasons for accepting or refusing the procedure. The purpose of this report was to describe the factors underlying acceptance or refusal of EA by nulliparous women. A total of 41 nulliparous women were included. Fourteen (34.14%) accepted LEA and 27 (63.86%) refused. Mean age was 27 years in the acceptance group and 25 years in the refusal group. No patient had good knowledge about LEA. Nulliparous women that accepted EA had a higher socio-economic level, expected stronger labor pain, were better informed about EA, and expressed greater confidence in medical care. In addition to economic aspects, the main reasons for refusing EA involved fear and family background.

Entities:  

Mesh:

Year:  2011        PMID: 22235633

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  1 in total

1.  The effect of epidural education on Primigravid Women's decision to request epidural analgesia: a cross-sectional study.

Authors:  Maha Heshaam Alakeely; Arwa Khalaf Almutari; Ghadah Abdulrhman Alhekail; Zainah Ahmad Abuoliat; Alaa Althubaiti; Laila Abdul-Rahman AboItai; Hanan Al-Kadri
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-03       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.